HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

SPINK1 mutations are associated with multiple phenotypes.

Abstract
Mutations in the gene encoding for the pancreatic secretory trypsin inhibitor or serine protease inhibitor, Kazal type I (SPINK1) have been associated with different entities of chronic pancreatitis. While there is no doubt about the involvement of SPINK1 mutations in pancreatic inflammatory disease, much controversy has arisen regarding which alterations are associated with disease and what type of disease model should be applied when the SPINK1 gene is examined. This article presents the existing data on SPINK1 mutations in idiopathic chronic pancreatitis, familial pancreatitis, hereditary pancreatitis and tropical pancreatitis. The possible role of SPINK1 mutations and polymorphisms in pancreatic disease is discussed.
AuthorsR H Pfützer, D C Whitcomb
JournalPancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] (Pancreatology) Vol. 1 Issue 5 Pg. 457-60 ( 2001) ISSN: 1424-3903 [Print] Switzerland
PMID12120224 (Publication Type: Journal Article, Review)
Chemical References
  • Trypsin Inhibitor, Kazal Pancreatic
Topics
  • Humans
  • Mutation (genetics)
  • Pancreatitis (genetics)
  • Phenotype
  • Trypsin Inhibitor, Kazal Pancreatic (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: